Koss-Olinger Consulting’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.5K Sell
16,751
-34,648
-67% -$126K 0.01% 169
2026
Q1
$203K Sell
51,399
-6,615
-11% -$33.3K 0.02% 246
2025
Q4
$393K Sell
58,014
-9,924
-15% -$69.6K 0.03% 188
2025
Q3
$415K Hold
67,938
0.03% 229
2025
Q2
$415K Sell
67,938
-5,154
-7% -$34.3K 0.03% 228
2025
Q1
$555K Buy
73,092
+62,730
+605% +$524K 0.05% 179
2024
Q4
$100K Buy
+10,362
New +$80.7K 0.01% 178

Other funds holding MDXG

Koss-Olinger Consulting's MDXG Position: Q2 2026 in Review

Koss-Olinger Consulting reduced its MiMedx Group (MDXG) stake by 67% in Q2 2026, selling an estimated $126K and leaving 16,751 shares worth $64.5K. The position accounts for 0.01% of the portfolio, ranked #169.

Koss-Olinger Consulting first reported a position in MDXG in Q4 2024 and has held it in 7 quarters since. The position peaked at $555K in Q1 2025. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Koss-Olinger Consulting held 16,751 shares of MiMedx Group worth $64.5K as of Q2 2026.
  • Koss-Olinger Consulting sold 34,648 MiMedx Group shares in Q2 2026, an estimated $126K.
  • MiMedx Group made up 0.01% of Koss-Olinger Consulting's portfolio in Q2 2026, its #169 holding.
  • Koss-Olinger Consulting first reported a position in MiMedx Group in Q4 2024 and has held it in 7 quarters since.
  • Koss-Olinger Consulting's MiMedx Group position peaked at $555K in Q1 2025.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Koss-Olinger Consulting's 13F filing for Q2 2026, filed 10 Aug 2026.